APA (7th ed.) Citation

J, S., DB, K., R, B., D, Z., F, S., JS, B., . . . CJ, L. (2025). PPP2R1A mutations cause ATR inhibitor sensitivity in ovarian clear cell carcinoma. Oncogene, 44(9), 618. https://doi.org/10.1038/s41388-024-03265-0

Chicago Style (17th ed.) Citation

J, Stewart, et al. "PPP2R1A Mutations Cause ATR Inhibitor Sensitivity in Ovarian Clear Cell Carcinoma." Oncogene 44, no. 9 (2025): 618. https://doi.org/10.1038/s41388-024-03265-0.

MLA (9th ed.) Citation

J, Stewart, et al. "PPP2R1A Mutations Cause ATR Inhibitor Sensitivity in Ovarian Clear Cell Carcinoma." Oncogene, vol. 44, no. 9, 2025, p. 618, https://doi.org/10.1038/s41388-024-03265-0.